Monday, September 14, 2026

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

AMERICA FIRST Diplomacy: Trump Dares to Face Kim Jong Un—The ONLY Leader Capable of Ending the Nuclear Nightmare

Trump expresses willingness to meet Kim Jong Un during his Asia tour, emphasizing sanctions as a key issue for negotiations.

“North Korean Banker In Shadows” Sim Hyon-sop: WSJ Names Him “Key Man For Crypto Laundering And Arms Procurement”

North Korean banker Shim Hyun Seop is linked to Kim Jong Un's financing network, evading sanctions through shell companies and cryptocurrency.

Tag: cancer drug

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Penetrium Bio to unveil U.S. Phase 2 strategy at global symposium

Penetrium Bio will unveil its Phase 2 clinical development strategy for the next-gen cancer drug Penetrium at a global symposium next month.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.